| ItsRxme vs Jin | 20–35 | 36.36% |
| ItsRxme vs King | 29–25 | 53.70% |
| ItsRxme vs Kazuya | 13–28 | 31.71% |
| ItsRxme vs Law | 15–20 | 42.86% |
| ItsRxme vs Steve | 14–21 | 40.00% |
| ItsRxme vs Dragunov | 17–15 | 53.12% |
| ItsRxme vs Hwoarang | 10–16 | 38.46% |
| ItsRxme vs Reina | 16–10 | 61.54% |
| ItsRxme vs Heihachi | 10–16 | 38.46% |
| ItsRxme vs Bryan | 5–18 | 21.74% |
| ItsRxme vs Asuka | 8–13 | 38.10% |
| ItsRxme vs Victor | 11–9 | 55.00% |
| ItsRxme vs Paul | 10–9 | 52.63% |
| ItsRxme vs Lili | 7–11 | 38.89% |
| ItsRxme vs Anna | 7–11 | 38.89% |
| ItsRxme vs Feng | 5–12 | 29.41% |
| ItsRxme vs Fahkumram | 7–10 | 41.18% |
| ItsRxme vs Jun | 9–7 | 56.25% |
| ItsRxme vs Clive | 6–10 | 37.50% |
| ItsRxme vs Devil Jin | 5–8 | 38.46% |
| ItsRxme vs Azucena | 5–8 | 38.46% |
| ItsRxme vs Eddy | 3–9 | 25.00% |
| ItsRxme vs Yoshimitsu | 2–8 | 20.00% |
| ItsRxme vs Xiaoyu | 2–8 | 20.00% |
| ItsRxme vs Nina | 4–6 | 40.00% |
| ItsRxme vs Leroy | 3–7 | 30.00% |
| ItsRxme vs Alisa | 2–7 | 22.22% |
| ItsRxme vs Kuma | 5–4 | 55.56% |
| ItsRxme vs Jack-8 | 1–7 | 12.50% |
| ItsRxme vs Lidia | 5–3 | 62.50% |
| ItsRxme vs Raven | 2–5 | 28.57% |
| ItsRxme vs Leo | 2–4 | 33.33% |
| ItsRxme vs Claudio | 3–3 | 50.00% |
| ItsRxme vs Lee | 3–3 | 50.00% |
| ItsRxme vs Shaheen | 2–2 | 50.00% |
| ItsRxme vs Lars | 2–1 | 66.67% |
| ItsRxme vs Zafina | 1–2 | 33.33% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.